MX2017016911A - Método para mejorar resultados en la salud. - Google Patents

Método para mejorar resultados en la salud.

Info

Publication number
MX2017016911A
MX2017016911A MX2017016911A MX2017016911A MX2017016911A MX 2017016911 A MX2017016911 A MX 2017016911A MX 2017016911 A MX2017016911 A MX 2017016911A MX 2017016911 A MX2017016911 A MX 2017016911A MX 2017016911 A MX2017016911 A MX 2017016911A
Authority
MX
Mexico
Prior art keywords
tissues
risk
followed
health outcomes
application
Prior art date
Application number
MX2017016911A
Other languages
English (en)
Spanish (es)
Inventor
Stephen T Woody
Original Assignee
Avadim Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/745,091 external-priority patent/US20160158393A1/en
Application filed by Avadim Tech Inc filed Critical Avadim Tech Inc
Publication of MX2017016911A publication Critical patent/MX2017016911A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/524—Preservatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
MX2017016911A 2015-06-19 2016-06-17 Método para mejorar resultados en la salud. MX2017016911A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/745,091 US20160158393A1 (en) 2014-02-21 2015-06-19 Method for Improving Health Outcomes
PCT/US2016/038043 WO2016205620A1 (en) 2015-06-19 2016-06-17 Method for improving health outcomes

Publications (1)

Publication Number Publication Date
MX2017016911A true MX2017016911A (es) 2019-06-24

Family

ID=56464282

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017016911A MX2017016911A (es) 2015-06-19 2016-06-17 Método para mejorar resultados en la salud.
MX2022005561A MX2022005561A (es) 2015-06-19 2017-12-19 Metodo para mejorar resultados en la salud.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022005561A MX2022005561A (es) 2015-06-19 2017-12-19 Metodo para mejorar resultados en la salud.

Country Status (6)

Country Link
EP (1) EP3310443A1 (https=)
JP (1) JP2018521992A (https=)
BR (1) BR112017027349B1 (https=)
CA (1) CA2989644A1 (https=)
MX (2) MX2017016911A (https=)
WO (2) WO2016205620A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10046137B2 (en) 2014-02-21 2018-08-14 Avadim Technologies, Inc. Method for maintenance of urethral catheters
CN107693457A (zh) * 2017-11-16 2018-02-16 东兴市良佳优农林科技有限公司 止痒洗发露
CN107737070A (zh) * 2017-11-16 2018-02-27 东兴市良佳优农林科技有限公司 杀菌、护肤洗手液
CA3143518A1 (en) 2019-06-12 2020-12-17 Avadim Health Ip, Inc. Compositions and methods for the antiseptic cleansing and biofilms treatment of mammalian tissue
JP2021155362A (ja) * 2020-03-27 2021-10-07 株式会社ナリス化粧品 ペルオキシナイトライト活性阻害方法および、ペルオキシナイトライト活性阻害剤のスクリーニング方法
JP2021159046A (ja) * 2020-04-03 2021-10-11 花王株式会社 皮膚情報提供方法
IT202000021634A1 (it) * 2020-09-16 2020-12-16 Prete Antonio Del Dispositivo per la somministrazione di una soluzione con iodiopovidone per la prevenzione delle infezioni dell'occhio

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10500868A (ja) * 1994-02-28 1998-01-27 インクライン・テクノロジーズ・インコーポレーテッド 皮膚を清潔にするための方法並びにシステム
US6358516B1 (en) 1998-08-21 2002-03-19 Norris R. Harod One-step system for cleansing, conditioning, and treating the skin
EP2563356A4 (en) * 2010-04-27 2013-10-16 St John S Medical Res Inst COMPOSITION FOR SKIN CARE AND PROTECTION AND METHOD OF USE THEREOF
US9327029B2 (en) * 2011-05-05 2016-05-03 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds

Also Published As

Publication number Publication date
WO2016205620A1 (en) 2016-12-22
CA2989644A1 (en) 2016-12-22
MX2022005561A (es) 2022-07-21
BR112017027349A2 (pt) 2018-08-21
EP3310443A1 (en) 2018-04-25
JP2018521992A (ja) 2018-08-09
WO2016205812A1 (en) 2016-12-22
BR112017027349B1 (pt) 2021-07-06

Similar Documents

Publication Publication Date Title
MX2017016911A (es) Método para mejorar resultados en la salud.
MX2016008694A (es) Dispositivo de avance mandibular, y metodo y kit de preparacion de dicho dispositivo.
UY38263A (es) Compuestos de purinona y su uso en el tratamiento del cáncer
MX391850B (es) Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington
PA8637201A1 (es) Difenilimidazopirimidina e-imidazol aminas como inhibidores de la b-secretasa
CL2013001436A1 (es) Composicion que comprende al menos una n-acetil-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; y su uso para la prevencion y/o tratamiento de las condiciones de la piel y enfermedades de la piel.
AR095054A1 (es) Aparato generador electrohidráulico (eh) de ondas de choque de pulsos rápidos, y métodos para tratamientos médicos y cosméticos
MX369474B (es) Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad.
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
AR122380A1 (es) Uso de inhibidores de sglt-2 para la prevención y/o tratamiento de enfermedades cardíacas en felinos
MX392677B (es) Composiciones para usarse en el tratamiento de trastornos neurodegenerativos en una población particular de pacientes.
AR054249A1 (es) Tratamiento de enfermedades del tejido conectivo de la piel
AR097997A1 (es) Composición farmaceutica de ibuprofeno y tramadol para uso oftálmico
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
BR112012015386B8 (pt) composição oftálmica tópica
CO6761349A2 (es) Proteína antimicrobiana
MX391376B (es) Composiciones de la membrana de la cáscara del huevo para usarse en el tratamiento de la cadena ligera kappa del factor nuclear de las células b activadas (nf-kb) en un organismo hospedero.
CO2021009034A2 (es) Composición para prevenir, mejorar o tratar enfermedades o síntomas relacionados con el cartílago que comprende hapln1
AR110913A1 (es) Compuesto aminoglucósido y su uso para prevenir o tratar enfermedades infecciosas
AR103903A1 (es) Composición cosmética reductiva de aplicación tópica
CO2022002493A2 (es) Nanoemulsion de ácido 18p-glicirretínico
CL2008000419A1 (es) Uso de una composicion alimenticia para mejorar el bienestar del pez, viabilidad o recuperacion mas rapida, y/o para la prevencion, alivio y/o tratamiento de salmonidos infectados con la enfermedad del pancreas; y composcion alimenticia para salmonid
MY174186A (en) Use of an isopropanol-containing solution to combat caliciviridae
CL2009001221A1 (es) Uso de un androgeno y/o un modulador selectivo del receptor de androgeno para preparar un medicamento para el tratamiento de la insuficiencia cardiaca o para retardar o detener el avance de la insuficiencia cardiaca en un sujeto humano de sexo femenino.
Duncan et al. Carpal Tunnel Nonoperative